Entera Bio President of R&D & Director resigns under separation deal with cash and option benefits

Entera Bio Ltd.

Dr. Phillip Schwartz resigns as President of R&D (effective July 21, 2022) and from Board (immediate); no disagreement.
Cash separation payment of ~$155,900 plus ~$213,952 in accrued benefits; also fully accelerated 100,000 option shares subject to shareholder approval.
Proposed consulting agreement for business development services with 14-day termination notice.
Schwartz agrees to non-disparagement, mutual release, and voting/standstill restrictions until after 2023 AGM.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Phillip Schwartz

Director

ENTXW · Entera Bio Ltd.

Effective: 2022-06-15
Filed: June 17, 2022, 7:59 PM ET

would resign from the Company’s Board of Directors (the “Board”), effective as of the Effective Date

Departed

Phillip Schwartz

President of Research & Development

ENTXW · Entera Bio Ltd.

Effective: 2022-07-21
Filed: June 17, 2022, 7:59 PM ET

Dr. Schwartz would resign from his position as the Company’s President of R&D, effective July 21, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Phillip Schwartz resigned as Director at Entera Bio Ltd..

Action: resigned
Role: Director

Exact text from the filing

would resign from the Company’s Board of Directors (the “Board”), effective as of the Effective Date

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Phillip Schwartz resigned as President of Research & Development at Entera Bio Ltd..

Action: resigned
Role: President of Research & Development

Exact text from the filing

Dr. Schwartz would resign from his position as the Company’s President of R&D, effective July 21, 2022

View on SEC.gov

Entera Bio Ltd. filing history →

Source: SEC EDGAR

accession 0001178913-22-002398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.